|Biological half-life||42 hours|
|Chemical and physical data|
|Molar mass||366.54 g/mol|
|3D model (Jmol)|
It is nonselective.
It has been implicated in causing ventricular arrhythmia (torsades de pointes).
In June 2015 a research paper  was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.
- Bezprozvanny I, Tsien RW (September 1995). "Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967)". Mol. Pharmacol. 48 (3): 540–9. PMID 7565636.
- Imai S, Saito F, Takase H, et al. (May 2008). "Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm". Circ. J. 72 (5): 709–15. doi:10.1253/circj.72.709. PMID 18441448.
- "A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity".
- "Zoloft as Ebola cure? Antidepressant is one of a number of promising drugs being looked at by scientists.".
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|